Download presentation
Presentation is loading. Please wait.
Published byJosephine Simpson Modified over 9 years ago
1
Molecular Biology of Cancer
2
CANCER TAKES TIME
3
CANCER IS A DISEASE OF GENETIC MUTATIONS ACCUMULATION OF MANY MUTATIONS CAUSES CANCER
4
YOU MUST REMEMBER THAT ALL MUTATIONS ARE RANDOM YOU WILL MUTATE DRIVERS AND PASSENGERS
5
WHAT MAKES A CANCER CELL A CANCER CELL? UNLIMITED GROWTH UNLIMITED MOVEMENT
7
Growth Factors int-2 sis Growth Factor Receptors erbB-1 fms kit met erbB-2 Cytoplasmic Kinases src bcr-abl fes lck yes Nuclear Proteins ets fos jun myc FGF PDGF EGF-R CSF-1R Stem Cell GF-R Hepatic GF-R Heregulin R FAMOUS ONCOGENES
9
The Cell Cycle
11
FAMILIAL CANCER SYNDROMES Li-Fraumeni p53 Deleted in Pancreas Smad4 Retinoblastoma Rb Breast Cancer Brca1,2 Wilms Tumor WT1 Nonpolyposis Colon MSH2,MLH1 Neurofibromatosis 1,2 NF1,NF2 von Hippel-Lindau VHL Adenomatous Polyposis APC Melanoma INK4a/ARF Cowden Disease PTEN Gorlin PTCH Multiple Endocrine Neoplasia MEN1
12
THE DEFINITION OF A TUMOR SUPPRESSOR Classical Features: 1.Loss of function mutations 2.Targeted allelic loss- Methylation or Deletion 3.Inherited mutations that predispose to cancer 4.Somatic mutation in spontaneous tumors 5.Ability to inhibit transformed cells in vitro
15
ACTIVATING THE p53 RESPONSE
16
p53 Modifications
17
ACCESSING THE CELL CYCLE MACHINERY
18
The Ink4a/Arf Locus
21
11 11 11 11 3 3 2 CpG DE-REPRESSION ONCOGENES RAS PRC1 PRC2 ARF INK4A
22
SELECTIVE PRESSURE THROUGH STRESS From environment: -Low oxygen -Low nutrients -Radiation -Ligands From self: -Random mutant -ROS -Grow too fast Dealing with it: -Arrest/Senesce -Apoptosis MUTATE
23
Not just division…But growth
25
Understanding what translation is really all about Growth signals PI-3k/mTOR Pathway And Regulators of Ribosome biogenesis 60S 40S 5’ AAAAAAAAAA-3 ’ UTR Active translationRibosome biogenesis rRNA synthesis rRNA processing rRNA export
26
PI3K GFR Akt Rheb Ras mTOR Tuberin/ Hamartin PTEN Neurofibromin Tuberous sclerosis complex Neurofibromatosis type 1 (NF1) Cowden Syndrome Lhermitte-Duclos disease S6KeIF4E NPM ARF p68
27
THINKING ABOUT TRANSLATION
28
THE NUCLEOLUS NPM ARF
29
MAKING RIBOSOMAL RNA
31
Micro RNA
32
PUTTING IT ALL TOGETHER 1. IDENTIFY THE MUTATIONS 2. SEPARATE DRIVERS FROM PASSENGERS 3. FIND DRUGGABLE TARGETS4. TEST IT ON THE RIGHT PATIENTS
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.